Download presentation
Presentation is loading. Please wait.
Published byHannele Virtanen Modified over 6 years ago
1
The Finnish experience to save asthma costs by improving care in 1987-2013
Tari Haahtela, MD, Fredrik Herse, MSc, Jussi Karjalainen, MD, Timo Klaukka, MD, Miika Linna, PhD, Riikka-Leena Leskelä, PhD, Olof Selroos, MD, Eeva Reissell, MD Journal of Allergy and Clinical Immunology Volume 139, Issue 2, Pages e2 (February 2017) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 Overall annual costs of asthma care at the societal level in Finland from 1987 to 2013. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Overall annual costs of asthma care at the patient level in Finland from 1987 to 2013. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
4
Fig 3 Actual (realized) annual expenditures of asthma care (blue columns) and minimum (red columns) and maximum (gray columns) scenarios of theoretic annual costs. The minimum scenario represents a theoretic annual expenditure if all of the 3-fold increase in prevalence was caused by patients with mild asthma. The maximum scenario assumes that the disease severity and standard of care remained at the 1987 level. The green line represents the percentage of patients receiving ICS medication. Journal of Allergy and Clinical Immunology , e2DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.